Floatz logo

cd19/bcma car t-cells

Autoimmune Hemolytic Anemia

Zhejiang UniversityCell therapyEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Autoimmune Hemolytic Anemia cohort.

Asset / SponsorPhaseRating
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
City of Hope Medical Center
Phase 2CCC
Ibrutinib
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2CCC
Acalabrutinib
City of Hope Medical Center
Phase 2CCC
(+)-VINCRISTINE
City of Hope Medical Center
Phase 2CCC
Inno-206
City of Hope Medical Center
Phase 2CCC

View all 9 →

Same molecule, other indications

cd19/bcma car t-cells is also rated in:

POEMS SyndromeDormant
C
Indicative ·
39 / 100
View asset →
AmyloidosisDormant
C
Indicative ·
39 / 100
View asset →
VasculitisDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →